244 related articles for article (PubMed ID: 28228148)
1. The effect of MElatonin on Depressive symptoms, Anxiety, CIrcadian and Sleep disturbances in patients after acute coronary syndrome (MEDACIS): study protocol for a randomized controlled trial.
Madsen MT; Isbrand A; Andersen UO; Andersen LJ; Taskiran M; Simonsen E; Gögenur I
Trials; 2017 Feb; 18(1):81. PubMed ID: 28228148
[TBL] [Abstract][Full Text] [Related]
2. The effect of melatonin on depressive symptoms and anxiety in patients after acute coronary syndrome: The MEDACIS randomized clinical trial.
Madsen MT; Zahid JA; Hansen CH; Grummedal O; Hansen JR; Isbrand A; Andersen UO; Andersen LJ; Taskiran M; Simonsen E; Gögenur I
J Psychiatr Res; 2019 Dec; 119():84-94. PubMed ID: 31586772
[TBL] [Abstract][Full Text] [Related]
3. Chronobiology, cognitive function and depressive symptoms in surgical patients.
Hansen MV
Dan Med J; 2014 Sep; 61(9):B4914. PubMed ID: 25186550
[TBL] [Abstract][Full Text] [Related]
4. Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: a randomized controlled trial.
Riemersma-van der Lek RF; Swaab DF; Twisk J; Hol EM; Hoogendijk WJ; Van Someren EJ
JAMA; 2008 Jun; 299(22):2642-55. PubMed ID: 18544724
[TBL] [Abstract][Full Text] [Related]
5. Effect of melatonin on depressive symptoms and anxiety in patients undergoing breast cancer surgery: a randomized, double-blind, placebo-controlled trial.
Hansen MV; Andersen LT; Madsen MT; Hageman I; Rasmussen LS; Bokmand S; Rosenberg J; Gögenur I
Breast Cancer Res Treat; 2014 Jun; 145(3):683-95. PubMed ID: 24756186
[TBL] [Abstract][Full Text] [Related]
6. Correlates and Escitalopram Treatment Effects on Sleep Disturbance in Patients with Acute Coronary Syndrome: K-DEPACS and EsDEPACS.
Kim JM; Stewart R; Bae KY; Kang HJ; Kim SW; Shin IS; Hong YJ; Ahn Y; Jeong MH; Yoon JS
Sleep; 2015 Jul; 38(7):1105-11. PubMed ID: 25581916
[TBL] [Abstract][Full Text] [Related]
7. Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light--a randomized clinical trial.
Most EI; Scheltens P; Van Someren EJ
Trials; 2010 Feb; 11():19. PubMed ID: 20178604
[TBL] [Abstract][Full Text] [Related]
8. Antidepressant action of melatonin in the treatment of Delayed Sleep Phase Syndrome.
Rahman SA; Kayumov L; Shapiro CM
Sleep Med; 2010 Feb; 11(2):131-6. PubMed ID: 20044310
[TBL] [Abstract][Full Text] [Related]
9. Effect of melatonin administration on sleep, behavioral disorders and hypnotic drug discontinuation in the elderly: a randomized, double-blind, placebo-controlled study.
Garzón C; Guerrero JM; Aramburu O; Guzmán T
Aging Clin Exp Res; 2009 Feb; 21(1):38-42. PubMed ID: 19225268
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertraline.
Kasper S; Hajak G; Wulff K; Hoogendijk WJ; Montejo AL; Smeraldi E; Rybakowski JK; Quera-Salva MA; Wirz-Justice AM; Picarel-Blanchot F; Baylé FJ
J Clin Psychiatry; 2010 Feb; 71(2):109-20. PubMed ID: 20193645
[TBL] [Abstract][Full Text] [Related]
11. Hypnotic and Melatonin/Melatonin-Receptor Agonist Treatment in Bipolar Disorder: A Systematic Review and Meta-Analysis.
McGowan NM; Kim DS; de Andres Crespo M; Bisdounis L; Kyle SD; Saunders KEA
CNS Drugs; 2022 Apr; 36(4):345-363. PubMed ID: 35305257
[TBL] [Abstract][Full Text] [Related]
12. The effect of MELatOnin on Depression, anxietY, cognitive function and sleep disturbances in patients with breast cancer. The MELODY trial: protocol for a randomised, placebo-controlled, double-blinded trial.
Hansen MV; Madsen MT; Hageman I; Rasmussen LS; Bokmand S; Rosenberg J; Gögenur I
BMJ Open; 2012; 2(1):e000647. PubMed ID: 22240653
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of melatonin with behavioural sleep-wake scheduling for delayed sleep-wake phase disorder: A double-blind, randomised clinical trial.
Sletten TL; Magee M; Murray JM; Gordon CJ; Lovato N; Kennaway DJ; Gwini SM; Bartlett DJ; Lockley SW; Lack LC; Grunstein RR; Rajaratnam SMW;
PLoS Med; 2018 Jun; 15(6):e1002587. PubMed ID: 29912983
[TBL] [Abstract][Full Text] [Related]
14. Impact of oral melatonin on critically ill adult patients with ICU sleep deprivation: study protocol for a randomized controlled trial.
Huang H; Jiang L; Shen L; Zhang G; Zhu B; Cheng J; Xi X
Trials; 2014 Aug; 15():327. PubMed ID: 25135124
[TBL] [Abstract][Full Text] [Related]
15. Agomelatine treatment corrects symptoms of depression and anxiety by restoring the disrupted melatonin circadian rhythms of rats exposed to chronic constant light.
Tchekalarova J; Stoynova T; Ilieva K; Mitreva R; Atanasova M
Pharmacol Biochem Behav; 2018 Aug; 171():1-9. PubMed ID: 29807067
[TBL] [Abstract][Full Text] [Related]
16. Escitalopram treatment for depressive disorder following acute coronary syndrome: a 24-week double-blind, placebo-controlled trial.
Kim JM; Bae KY; Stewart R; Jung BO; Kang HJ; Kim SW; Shin IS; Hong YJ; Kim JH; Shin HY; Kang G; Ahn Y; Kim JK; Jeong MH; Yoon JS
J Clin Psychiatry; 2015 Jan; 76(1):62-8. PubMed ID: 25375836
[TBL] [Abstract][Full Text] [Related]
17. Bright light treatment in elderly patients with nonseasonal major depressive disorder: a randomized placebo-controlled trial.
Lieverse R; Van Someren EJ; Nielen MM; Uitdehaag BM; Smit JH; Hoogendijk WJ
Arch Gen Psychiatry; 2011 Jan; 68(1):61-70. PubMed ID: 21199966
[TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapies for sleep disturbances in dementia.
McCleery J; Cohen DA; Sharpley AL
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD009178. PubMed ID: 27851868
[TBL] [Abstract][Full Text] [Related]
19. A randomised controlled trial assessing the severity and duration of depressive symptoms associated with a clinically significant response to sertraline versus placebo, in people presenting to primary care with depression (PANDA trial): study protocol for a randomised controlled trial.
Salaminios G; Duffy L; Ades A; Araya R; Button KS; Churchill R; Croudace T; Derrick C; Dixon P; Dowrick C; Gilbody S; Hollingworth W; Jones V; Kendrick T; Kessler D; Kounali D; Lanham P; Malpass A; Peters TJ; Riozzie D; Robinson J; Sharp D; Thomas L; Welton NJ; Wiles N; Lewis G
Trials; 2017 Oct; 18(1):496. PubMed ID: 29065916
[TBL] [Abstract][Full Text] [Related]
20. Melatonergic drugs in clinical practice.
Hardeland R; Poeggeler B; Srinivasan V; Trakht I; Pandi-Perumal SR; Cardinali DP
Arzneimittelforschung; 2008; 58(1):1-10. PubMed ID: 18368944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
